Guidance
Pneumococcal Vaccine: Handling the change in product manufacturer and presentation
Summary guidance for national authorities and immunization programme managers for the switch from GlaxoSmithKline Biologicals SA Synflorix® (PCV 10) to Pfizer Prevenar13® vaccine (PCV 13)
Authors
Languages
- Portuguese
Publication year
2017
Type
Categories
Diseases
Organisations